Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/2003
05/28/2003EP0871457B1 Isolated stromal cells and methods of using the same
05/28/2003EP0814792B1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
05/28/2003EP0788509B1 Therapeutic peptide derivatives
05/28/2003CN1420924A Recombinant human alpha-L-iduronidase, method for producing and purifying same and method for treating disorders including deficiency thereof
05/28/2003CN1420878A Compound with growth hormone releasing properties
05/28/2003CN1420872A Caspase inhibitors and use thereof
05/28/2003CN1420870A Modulators of dopamine neurotransmission
05/28/2003CN1420869A Modulators of dopamine neurotransmission
05/28/2003CN1420797A Method for improvement of islet signaling in diabetes mellitus and for its prevention
05/28/2003CN1420779A Nucleoside analogs with carboxamidine-modified bicyclic base
05/28/2003CN1420778A Remedies for periodontosis
05/28/2003CN1420770A Method of delivery of cetyl myristoleate
05/28/2003CN1420759A Slimming composition contg. substance inducing IL-6 production
05/28/2003CN1420755A Method and composition for treatment of scars
05/28/2003CN1419921A Chinese medicine capsule for treating diabetes
05/28/2003CN1419912A Cyanidenon, apigenin -7-0-beta-D-glucoside use and related medicine
05/28/2003CN1109683C 2-arylbenzo [b] thiophenes useful for treatment of estrogen deprivation syndrome
05/28/2003CN1109681C Flavone chromium, its producing method and use thereof
05/28/2003CN1109553C Chinese medicine capsule for treating diabetes
05/28/2003CN1109549C Soft concentrated fish oil capsule and its supercritical CO2 extraction and rectification process
05/27/2003US6569997 Antibody specific for H4-1BB
05/27/2003US6569996 Antibody that specifically binds to the cadherin-5 cell adhesion recognition sequence
05/27/2003US6569905 Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
05/27/2003US6569904 Via administration of toremifene for treatment or prevention of systemic/pulmonary hypertension, fibrosis, bronchial asthma, respiratory distress syndrome, myocardial infarction, thrombosis, congestive heart failure, and renal failure
05/27/2003US6569887 (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake
05/27/2003US6569884 Conformationally rigid bicyclic and adamantane derivatives useful as α2-adrenergic blocking agents
05/27/2003US6569873 Azolidines as beta-3 adrenergic receptor agonists
05/27/2003US6569871 Substituted imidazole compounds
05/27/2003US6569861 Melanin concentrating hormone receptor ligands
05/27/2003US6569856 Treatment of feeding disorders, obesity, bulimia nervosa, sexual/reproductive disorders, depression, epileptic seizure, cardiovascular disorders, sleep disturbances
05/27/2003US6569855 Particularly zinc metalloprotease activity for treatment of variety of maladies involving inflammation and/or tissue integrity
05/27/2003US6569849 N-Substituted azaheterocyclic compounds
05/27/2003US6569835 Hypolipidemics; treating obesity and disorders of lipid metabolism
05/27/2003US6569661 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
05/27/2003US6569463 Encapsulation coat includes different combinations of pharmaceutical active ingredients, hydrophilic and lipophilic surfactants, and triglycerides
05/27/2003US6569428 For regulating angiogenesis; nucleic acid encoding an endothelial cell mitogen and endothelial cell progenitors, where the EC progenitors are CD34+, Flk-1+, and tie-2+
05/27/2003US6569416 Compositions containing synthetic soil-extract materials and medicaments based thereon
05/27/2003CA2412624A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurogenerative diseases
05/27/2003CA2412466A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
05/27/2003CA2310960C Phosphate-binding polymers for oral administration
05/27/2003CA2268438C Hesperidin and hesperetin as 3-hydroxy-3-methylglutaryl coa(hmg-coa) reductase inhibitor
05/27/2003CA2231558C .gamma.-rar antagonist ligand or .alpha.-rar agonist ligand as an apoptosis inhibitor
05/27/2003CA2084961C Tissue protective tocopherol analogs
05/27/2003CA2066104C Benzazepine derivatives as vasopressin antagonists
05/22/2003WO2003042397A2 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003WO2003042390A1 Mammalian protein phosphatases
05/22/2003WO2003042381A1 Three-dimensional structure of prostaglandin d synthase and utilization thereof
05/22/2003WO2003042377A1 Expansion of t cells in vitro and expanded t cell populations
05/22/2003WO2003042362A2 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
05/22/2003WO2003042359A2 Histamine receptor h3 polynucleotides
05/22/2003WO2003042358A2 Methods of using 48149, a human aminopeptidase family member
05/22/2003WO2003042357A2 Enzymes
05/22/2003WO2003042218A1 Novel compounds
05/22/2003WO2003042216A1 Polycyclic guanine derivative phosphodiesterase v inhibitors
05/22/2003WO2003042214A2 A2b adenosine receptor antagonists
05/22/2003WO2003042213A1 Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
05/22/2003WO2003042211A1 Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase
05/22/2003WO2003042207A1 Thiazolyl substituted triazoles as alk5 inhibitors
05/22/2003WO2003042205A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003WO2003042204A1 Amine derivative
05/22/2003WO2003042194A1 Carboxylic acid derivative compounds and drugs containing the same as the active ingredient
05/22/2003WO2003042191A1 Benzamide and heteroarylamide as p2x7 receptor antagonists
05/22/2003WO2003042190A1 N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
05/22/2003WO2003042185A1 Xanthine oxidase inhibitors
05/22/2003WO2003042179A1 Heterocyclic derivatives of glycinamide and their medical use
05/22/2003WO2003042174A1 Cannabinoid receptor ligands
05/22/2003WO2003042173A1 Nk1 antagonists
05/22/2003WO2003041738A1 Treatment of metabolic disorders with xitar agonists and antagonists
05/22/2003WO2003041730A1 Ditacin agonists and antagonists for use in the treatment of metabolic disorders
05/22/2003WO2003041729A1 Ptp1b inhibitors and ligands
05/22/2003WO2003041727A2 Plant derived or derivable material with appetite suppressing activity
05/22/2003WO2003041721A1 Process for reacting alkaloids and use of the reaction products in the preparation of medicaments
05/22/2003WO2003041717A1 Persistent filmy preparation for topical administration containing prostaglandin derivative
05/22/2003WO2003041715A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
05/22/2003WO2003041708A1 Benzimidazoles useful as protein kinase inhibitors
05/22/2003WO2003041707A1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
05/22/2003WO2003041706A1 Pharmaceutical composition comprising a glitazone and a thiazolidinedione derivative, and use thereof for treating diabetes
05/22/2003WO2003041698A1 Amino acid-containing tablets quickly disintegrating in the oral cavity and process for producing the same
05/22/2003WO2003041697A1 Method for treating autoimmune diseases
05/22/2003WO2003041684A2 Injectable depot compositions and uses thereof
05/22/2003WO2003041679A2 Product containing a red alga extract of the genus porphyra and uses thereof for protecting cells
05/22/2003WO2003041649A2 Cyanoalkylamino derivatives as protease inhibitors
05/22/2003WO2003024943A3 Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis
05/22/2003WO2003020763A3 Soluble t cell receptor
05/22/2003WO2002098438A9 Compositions containing an active fraction isolated from scutellariae barbatae and methods of use
05/22/2003WO2002096362A3 Method for treating fibrotic diseases or other indications vi
05/22/2003WO2002085886A3 Chiral, broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions
05/22/2003WO2002083120A3 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
05/22/2003WO2002060419A3 A substance for use in a dietary supplement or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
05/22/2003WO2002044183A3 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors
05/22/2003WO2002041879A3 Antidiabetic compositions containing a biguanide and a sulfonamide
05/22/2003WO2002030924A9 Quinazoline derivatives with anti-tumour activity
05/22/2003WO2001070941A9 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis
05/22/2003US20030096992 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
05/22/2003US20030096866 Methods for activating lipid catabolism and improving lipid metabolism in small intestinal epithelium
05/22/2003US20030096857 Novel antidiabetic agents
05/22/2003US20030096852 Inhibiting binding interaction between hGH (human growth hormone) or a mutant thereof and an hGH binding protein or receptor in mammal administering benzimidazole compound
05/22/2003US20030096844 Cannabinoid receptor ligands
05/22/2003US20030096838 Novel triazolo-pyridines anti-inflammatory compounds
05/22/2003US20030096833 Use in inhibiting inflammation, cell death and in treating shock and reperfusion injuries
1 ... 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 ... 1298